Development and characterization of a novel nano-liposomal formulation of Alendronate Sodium loaded with biodegradable polymer
ABSTRACT Background: Alendronate Sodium (ALDS) is the drug of choice for treatment of osteoporosis. However, 50% of the osteoporotic patients ceased the treatment within the first year due to its potential side effect on the gastrointestinal tract (GIT). Objective: The current study aimed to utilize...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Libro |
| Publicado: |
Facultad de Farmacia, Universidad de Granada.
|
| Materias: | |
| Acceso en línea: | Connect to this object online. |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Clasificación: |
A1234.567 |
|---|---|
| Copia 1 | Disponible |